Week 456 Review - Great gains over much of the portfolio.

A pretty good week, with many of my top shares increasing in value, but tempered by yet another drop in PBX:Probiotix Health, which is falling so far that I'll soon stop reporting on its price movements. The deficit between cost and value improved by £1,436 to £111,820, the deficit between injection and value is now £46,881, with total portfolio value £104,297.

PBX:Probiotix Health drifted another 0.5p which is 13% to go 83% down, with no sign of the CEO making any effort whatsoever to maintain shareholder interest and the appearance of no progress in anything that was meant to be happening.

That was the only big faller.

APAX:Apax Global Alpha went up 5% but is still 21% down, although only 10% down if you include dividends.

IGG:IG Group also climbed 5% and is now only 7% down, which is the best for a long time. The improvement was helped by me doubling my holding when the price was low.

AJB:AJ Bell has been on an amazing run and went up another 9% this week, so is now 11% in profit, or 13% if you include dividend.

JLP:Jubilee Metals is now my 2nd largest holding, and much of this week's increase was due to the 9% improvement.

Share Of the Week is CWR:Ceres Power, which zoomed up 20% and is now only 17% down. This has been incredibly volatile, but I'm hoping as more contracts are signed they will get back towards the 1200p they were at 2.5 years ago. That would be six times what I bought them for.

Here's the ISA and shares portfolio after week 40 of year 9.

			Weekly Change
Cash	£65.94		+£0.15
Portfolio cost	£105,005.30		+£0
Portfolio sell value (bid price-commission)	£47,241.51	(-55.0%)	+£1,396.54
Potential profits	£1,204.82		+£591.84
Yr 9 Dividends	£245.03		+£0
Yr 9 Interest	£3.95		+£0
Yr 9 Profit from sales	£262.11		+£0
Yr 9 proj avg monthly profit	£48.06	(0.8%)	-£1.65
Total Dividends	£12,156.46		+£0
Total Interest	£5.88		+£0
Total Profit from sales	£17,560.64		+£0
Average monthly cash profit	£278.22	(4.4%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	38%		+0%

The £591 increase in potential profits was all JLP:Jubilee Metals, as OPTI:Optibiotix was flat this week. Nice increase in overall value but not much else happened.

Nice tweak upwards

Not enough of a tweak upwards!

The SIPP looks like this after week 440 overall and week 24 of year 9.

			Weekly Change
Cash	£326.41		+£236.06
Portfolio cost	£108,582.45		+£496.79
Portfolio sell value (bid price - commission)	£55,150.70	(-49.2%)	-£55.36
Potential profits	£3,213.57		-£289.81
Yr 9 Dividends	£302.35		+£0
Yr 9 Interest	£2.74		+£0
Yr 9 Profit from sales	£4,004.44		+£497.69
Yr 9 proj avg monthly profit	£758.43	(12.6%)	+£57.65
Total Dividends	£14,902.59		+£0
Total Interest	£8.67		+£0
Total Profit from sales	£14,840.34		+£497.69
Average monthly cash profit	£280.88	(4.7%)	+£4.11
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

I sold my PLUS:Plus500 shares as I was concerned there may be sanctions against Israel and I don't want a repeat of the POLY:Polymetal debacle. I sold my 69 shares at 2184.6199p making £497.69 (49.2%) profit, and also have a dividend coming in July.

I used some of the proceeds to buy 96 shares in ARBB:Arbuthnot Banking at 1031.85p and costing £1,002.53. They are one of my magic formula shares and they have been making a bit of a recovery lately so I'm hoping it will continue.

I also topped up my holding in CAML:Central Asia Metals, buying 226 shares at 212.4142p and costing £492.01. That takes my SIPP holding to 3,986 shares at an average price of 177.24p costing £7,124. I'm happy to say they are at potential profit of £1,293 and 18% up, with a socking great £300+ dividend coming in a few weeks.

The profit-taking meant my portfolio value dropped, but only by £55, and potential profit would have gone up by about £200 if not for the sale, but dropped by £289 as a result. My year 9 performance improved, and as long as I don't make any losses, I'm on for at least 5.8% profit from sales. Long term performance hardly changed.

Quite flat

Very flat.

The trading account looks like this after week 406 overall and week 42 of year 8.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,449.07	(-30.1%)	+£95.70
Potential profits	£81.90		+£51.20
Year 8 Dividends	£25.36		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£36.47	(+21.1%)	-£0.89
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.52	(-3.2%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

A great week with the 9% increase in JLP:Jubilee Metals. I'm still holding out for 11.5p before I sell my first lot, as I need to earn big to turn around my massive deficit after DDDD:4D Pharma went bust. SBTX:SkinBioTherapeutics was flat this week, which is better than usual.

Nearly back where we were a few weeks ago.

Back to being well above the trend line, which may even pivot back upwards soon.

I'm hoping the momentum will be with JLP:Jubilee Metals now, as we near the completion of the Roan copper upgrades. With copper soaring we're not taking advantage of that as people don't see JLP as a copper producer. If that changes then the re-rate is on.

Most of my holding is in the ISA where I have 176,000 shares. Much more than I had last time I went big on JLP. I also have 54,000 in my dealing account, but I need to sell those and take them out to pay for my holiday, after I lent my ISA enough to buy the same number of shares where I can protect any profits from tax. I also have 69,000 in my SIPP, and I want to sell those as soon as they break even, as it will liberate £6,500 for magic formula shares.

I'm hoping for some excitement with these over the next few weeks, as I'm pretty sure I won't get any anywhere else.

Week 455 Review - A fairly flat week, but another down week.

It wasn't a bad week for most of the portfolio, but a drop in JLP:Jubilee Metals was enough to widen the deficit between cost and value by £332 to £113,257, with the deficit between cost and injection amount £48,500 and total portfolio value of £102,127.

There were no major fallers, which was nice.

POLY:Polymetal went up 6% after a 5% rise last week, so will hopefully stage a bit of a recovery before re-listing in the UK when the Russian assets are sold. They are still 82% down so have a long way to go.

FXPO:Ferrexpo zoomed up 9% but are still 90% down and will be until Russia get out of Ukraine.

CAPD:Capital went up 9% after a 6% rise last week and are now only 6% down. These are still in my dealing account, so I will sell them if they get into profit and add the cash to my ISA where it will be invested in a potential growth share. I'll get back into CAPD:Capital when I next have a SIPP transfer as I do like them.

Share of the week is CWR:Ceres Power which tends to go up and down like a yo-yo and is a potential future share for my trading account. They went up 11% this week but are still 31% down.

Here's the ISA and shares portfolio after week 39 of year 9.

			Weekly Change
Cash	£65.79		+£0
Portfolio cost	£105,005.30		+£0
Portfolio sell value (bid price-commission)	£45,544.97	(-56.3%)	-£259.70
Potential profits	£612.98		+£0
Yr 9 Dividends	£245.03		+£0
Yr 9 Interest	£3.95		+£0
Yr 9 Profit from sales	£262.11		+£0
Yr 9 proj avg monthly profit	£49.71	(0.8%)	-£1.31
Total Dividends	£12,156.46		+£0
Total Interest	£5.88		+£0
Total Profit from sales	£17,560.64		+£0
Average monthly cash profit	£278.87	(4.4%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	38%		+0%

Very little change. Most of my JLP:Jubilee Metals holding is in the ISA so a 0.2p drop was enough to wipe out all the other gains and drop the value by £259.

A long, slow decline

I have about 2 months before the period starts with the peak from about 10 months ago, at which point the trend line will be very much downwards. I need about £12k improvement to get back to the trend line.

The SIPP looks like this after week 439 overall and week 23 of year 9.

			Weekly Change
Cash	£90.35		-£122.72
Portfolio cost	£108,085.66		+£485.22
Portfolio sell value (bid price - commission)	£54,709.27	(-49.4%)	-£41.12
Potential profits	£3,503.38		+£2.48
Yr 9 Dividends	£302.35		+£0
Yr 9 Interest	£2.74		+£0
Yr 9 Profit from sales	£3,506.75		+£0
Yr 9 proj avg monthly profit	£700.78	(11.7%)	-£31.85
Total Dividends	£14,902.59		+£0
Total Interest	£8.67		+£0
Total Profit from sales	£14,342.65		+£0
Average monthly cash profit	£276.77	(4.6%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

I had some dividends and a tax rebate from the last few weeks so added £300 to the account so I could buy something new. I got 29 shares in EDV:Endeavour Mining at 1647.6955p costing £485.22. Happy to say they ended the week £4 in profit.

Portfolio value hardly changed, as I'm much less exposed to JLP:Jubilee Metals here. The 2% drop in CAML:Central Asia Metals was the main reason for the negative week.

Injection amount goes up, value stays flat.

Very similar pattern to the ISA, but hoping it will diverge as I get rid of all my non-dividend shares from here.


The trading account looks like this after week 405 overall and week 41 of year 8.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,353.37	(-34.7%)	-£31.90
Potential profits	£30.70		-£17.17
Year 8 Dividends	£25.36		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£37.36	(+21.6%)	-£0.94
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.53	(-3.2%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

The 2% drop in JLP:Jubilee Metals dropped this £31. I maybe should have sold my profitable holding earlier, but I'm determined to hold out for a decent return.

It was looking so promising a few weeks ago, but less so now.

Plunging towards the trend line which is still pointing downwards.

The way things are going I fear it will be months rather than weeks before any news that might cause a turnaround in my fortunes. I guess I should be pleased that I have more profitable shares than at any time I can remember, with 11 lines of my spreadsheet green. In the past I would have sold them, but my new "hold dividend shares forever" mentality is now set in. Let's see if it's more successful than when I was trading.

Looking back at my most successful shares, it was the likes of IQE:IQE, SBTX:SkinBioTherapeutics, JLP:Jubilee Metals, CAML:Central Asia Metals and even OPTI:Optibiotix, and in every single case I would have lost all my profits if I hadn't sold when I did. So whereas this hold forever method may work ok for FTSE shares, I think I'll need to continue selling at least some in my ISA where I'll have a much higher risk profile.

Week 454 Review - Utter disaster wiping out all recent gains

Utter misery, with big drops all over the place. OPTI:Optibiotix falling 1.5p, JLP:Jubilee Metals falling .6p, and PBX:Probiotix Health falling 1p all making big contributions to the deficit between cost and value widening by £7,047 to £112,924, deficit between injection amount and value increasing to £48,530 and total value dropping to £102,297.

PBX:Probiotix Health was the worst performer, as a 1p drop was 20% and cost me about £1,000. These will continue drifting until they list on AIM, as it's so hard to trade them.

JLP:Jubilee Metals fell 8%, and given I've just bought lots more that cost me a big chunk of the week's losses.

OPTI:Optibiotix also dropped 8% and that cost me about £3,000 this week.

PAGE:Pagegroup fell 8% after underwhelming results

AFC:AFC Energy is very volatile and dropped 7% to go back into loss.

SBTX:SkinBioTherapeutics is also one of my major holdings and dropped 5% on no news.

FXPO:Ferrexpo managed to climb 5% after a good production update, but they are 91% down so it made little difference.

PLUS:Plus 500 has been growing steadily, and went up another 5% to go 44% up.

POLY:Polymetal crashed after announcing selling off the Russian assets, but is starting to recover a little, with a 5% rise this week.

Share of the Week is CAPD:Capital which went up 6% and is being tipped heavily, so I'm hoping may get into profit soon as they are still 14% down.

Here's the ISA and shares portfolio after week 38 of year 9.

			Weekly Change
Cash	£65.79		-£3.63
Portfolio cost	£105,005.30		+£2,699.98
Portfolio sell value (bid price-commission)	£46,104.67	(-56.1%)	-£3,709.74
Potential profits	£612.98		-£918.17
Yr 9 Dividends	£245.03		+£0
Yr 9 Interest	£3.95		+£0.08
Yr 9 Profit from sales	£262.11		+£0
Yr 9 proj avg monthly profit	£51.02	(0.8%)	-£1.81
Total Dividends	£12,156.46		+£0
Total Interest	£5.88		+£0.08
Total Profit from sales	£17,560.64		+£0
Average monthly cash profit	£279.48	(4.4%)	-£0.65
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	38%		-2%

I decided to "borrow" £2,700 from my holiday savings and add it to my ISA so I could buy JLP:Jubilee Metals while they are cheap, then sell my dealing account shares for a small profit so I can return my holiday savings. There is an element of risk with this plan if JLP stays low until I need to pay for my holiday, but I didn't want to use bed & isa because the price can move so fast, so this way I keep complete control as I now have my ISA holding and can sell the others at the appropriate time. If the price does drop I'll need to sell some premium bonds to pay for my holiday, but lets be optimistic. I firmly believe when Roan is announced as up to capacity there will be a significant re-rate.

I bought 39,702 shares at 6.788p costing £2,699.97. The bid price ended up at 6.7p so these are losing a little but only due to spread.

Sell value and profits plummeted but not much else changed.

Big injection and still the green line turns downwards.

Yuck!

The SIPP looks like this after week 438 overall and week 22 of year 9.

			Weekly Change
Cash	£213.07		+£32.83
Portfolio cost	£107,600.44		+£0
Portfolio sell value (bid price - commission)	£54,265.17	(-49.6%)	-£3,231.68
Potential profits	£3,500.90		-£469.27
Yr 9 Dividends	£302.35		+£34.64
Yr 9 Interest	£2.74		+£0.15
Yr 9 Profit from sales	£3,506.75		+£0
Yr 9 proj avg monthly profit	£732.63	(12.2%)	-£28.12
Total Dividends	£14,902.59		+£0
Total Interest	£8.67		+£0.15
Total Profit from sales	£14,342.65		+£0
Average monthly cash profit	£277.40	(4.6%)	-£0.31
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

I got a £34 dividend from RIO:Rio Tinto and profits and value also plummeted here, but not much else happened.

Same as ISA

Yuck again

The trading account looks like this after week 404 overall and week 40 of year 8.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,385.27	(-33.2%)	-£105.71
Potential profits	£47.77		-£51.19
Year 8 Dividends	£25.36		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£38.30	(+22.2%)	-£0.98
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.55	(-3.2%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

Big drops in all my holdings made this one of the worst weeks ever, and just as I thought things were looking up.

I guess we're still much higher than a few weeks ago.

That's really horrible.

I'm a week late writing this as my heart wasn't in it last week. One day things may turn around for my biggest holdings but it's not looking like it will be any time soon.

Week 453 Review - A great week for most of my portfolio

Although OPTI:Optibiotix remained unchanged this week, many shares in my portfolio did really well, so the deficit between cost and value improved by £2,904 to £105,877 and the deficit between injection amount and value reduced to £41,512. Overall portfolio value increased to £106,415.

Only one share had a big drop, and amazingly that was POLY:Polymetal. Given the price of gold is at an all-time high, and given the shares were already 82% down as a result of sanctions and moving off the UK stock market, they still dropped another 6% this week. The sooner they can get the cash for their Russian assets and pay off their debts, the sooner they can get some sort of recovery based on their remaining assets.

CAML:Central Asia Metals had a great week, climbing 6% and going 23% into profit in my SIPP.

JLP:Jubilee Metals went up 7% and my best holding is now up by 8%, although many of my holdings are still 40% down.

EDV:Endeavour Mining climbed 8% thanks to the gold rally, but they are still 8% in the red so I need another week like this one to get them into profit.

IPX:Impax Asset Management has been very volatile lately, usually in the wrong direction, but this week they ended 8% up and are only 9% down overall now.

RIO:Rio Tinto also rose 8% on improving metal prices.

PLUS:Plus 500 has been steadily climbing, and went up 9% this week to go 37% up overall.

CEY:Centamin has really benefited from the gold price rise, and went up 11% this week to go 22% up altogether.

Another gold miner going great guns is PAF:Pan African Resources, which also went up 11% this week to go 43% and 39% up in my 2 holdings.

Share of the Week is AFC:AFC Energy which went up by 14% and is now 1% in profit.

Here's the ISA and shares portfolio after week 37 of year 9.

			Weekly Change
Cash	£69.42		+£0
Portfolio cost	£102,305.32		+£1,300
Portfolio sell value (bid price-commission)	£47,114.43	(-53.9%)	+£1,036.85
Potential profits	£1,531.15		+£607.81
Yr 9 Dividends	£245.03		+£0
Yr 9 Interest	£3.87		+£0
Yr 9 Profit from sales	£262.11		+£0
Yr 9 proj avg monthly profit	£52.83	(0.9%)	-£1.46
Total Dividends	£12,156.46		+£0
Total Interest	£5.80		+£0
Total Profit from sales	£17,560.64		+£0
Average monthly cash profit	£280.13	(4.6%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		-1%

I added £1,300 to my ISA to start up a new one for 2024, but the intention is to sell one of my holdings in the dealing account and take the money out to replace the £1,300. I'd rather do it that way then risk a bed & isa where time delays and big spreads can be a problem. I just need to price to go up a little more so I'm selling for the same price Or above what I paid.

I bought 17,500 shares in JLP:Jubilee Metals for 7.4p costing £1,300.

Great rise in portfolio value and £607 rise in potential profits is mainly thanks to JLP:Jubilee Metals, but a little is from AFC:AFC Energy going £15 into profit.

Still a wide gap between value and injection.

Still below the trend line by some way.

The SIPP looks like this after week 437 overall and week 21 of year 9.

			Weekly Change
Cash	£180.24		-£248.83
Portfolio cost	£107,600.44		+£248.83
Portfolio sell value (bid price - commission)	£57,496.85	(-46.6%)	+£1,788.40
Potential profits	£3,970.17		+£1,161.77
Yr 9 Dividends	£267.71		+£0
Yr 9 Interest	£2.59		+£0
Yr 9 Profit from sales	£3,506.75		+£0
Yr 9 proj avg monthly profit	£760.75	(12.7%)	-£38.03
Total Dividends	£14,902.59		+£0
Total Interest	£8.52		+£0
Total Profit from sales	£14,342.65		+£0
Average monthly cash profit	£277.71	(4.6%)	-£0.64
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

I did my monthly investment, buying 177 shares in UKW:Greencoat UK Wind at 139.04p costing £248.83. That was the same number of shares I bought last month as the price is pretty much the same.

Portfolio value soared, as did potential profits, with CEY:Centamin, PAF:Pan African Resources and PLUS:Plus 500 contributing the most.

A bit more of a tick up than the ISA

Trend line is pointing more steeply upwards in this one, but we're still well below it.

The trading account looks like this after week 403 overall and week 39 of year 8.

			Weekly Change
Cash	£63.39		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,490.98	(-28.1%)	+£79.75
Potential profits	£98.96		+£42.66
Year 8 Dividends	£25.36		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£39.28	(+22.7%)	-£1.03
Dividends	£85.46		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.56	(-3.2%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

Great news for this account as JLP:Jubilee Metals is 3/5 of the holding, and the rise saw an increase in potential profits as well as a reduction in risk elsewhere. I've set my sell target at 11.5p which would give me another £500 to buy shares with, but wouldn't wipe out the long term deficit.

Nice.

Soared above the trend line, but not enough to change its direction yet.

I don't think I've ever had such a good week when OPTI:Optibiotix hasn't gone up at all. Hopefully gold will hold out for a while at these prices, and a bit of Roan news from JLP:Jubilee Metals would be useful.

Week 452 Review - Ended just in the black thanks to Jubilee Metals rise off-setting Optibiotix fall.

OPTI:Optibiotix tried to spoil the week by dropping 1p, but a massive surge in JLP:Jubilee Metals made up for those losses and the deficit between cost and value narrowed by £170 to £108,782, with deficit between injection and value standing at £44,417 and total portfolio value at £102,210.

Worst performer was SBTX:SkinBioTherapeutics, which wasn't a surprise given the massive and unexplained surge the week before. They dropped 24% which cost me a lot.

IPX:Impax Asset Management fell 7% for no particular reason, which is troubling as I don't expect these companies to be so volatile.

AJB:AJ Bell had a bad week and dropped 6%. Shame I'm no longer buying these each month.

OPTI:Optibiotix fell 1p which was 5% and will no doubt drift until we get some decent news.

WHR:Warehouse REIT have been doing a bit better lately, but fell 5% this week and are now 30% down.

Gold had a good week, and so did most of my miners. CEY:Centamin climbed 5% to go 10% up and EDV:Endeavour Mining climbed 6% but is still 15% down. Unfortunately PAF:Pan African Resources dropped 1%, but that's probably profit taking after the recent sharp rise.

PAGE:Pagegroup surprisingly went up 10% this week and are only 2% down now.

Share of the Week by a mile was JLP:Jubilee Metals which rocketed 24% and vindicated my decision to buy a load while they were cheap. Some are now in potential profit, but I'll be keeping them long-term in my ISA. The SIPP shares will get sold when they are making a decent profit, but both SIPP holdings are still 30% down.

Here's the ISA and shares portfolio after week 36 of year 9.

			Weekly Change
Cash	£69.42		+£25.46
Portfolio cost	£101,005.32		+£0
Portfolio sell value (bid price-commission)	£44,777.58	(-55.7%)	+£169.33
Potential profits	£923.34		-£23.31
Yr 9 Dividends	£245.03		+£29.11
Yr 9 Interest	£3.87		+£0.10
Yr 9 Profit from sales	£262.11		+£0
Yr 9 proj avg monthly profit	£54.29	(0.9%)	+£1.60
Total Dividends	£12,156.46		+£29.11
Total Interest	£5.80		+£0.10
Total Profit from sales	£17,560.64		+£0
Average monthly cash profit	£280.75	(4.7%)	-£0.38
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Cash went up £25 thanks to an £11 dividend from WHR:Warehouse REIT and £17 from ASHM:Ashmore Group, minus monthly fees and plus 10p interest.

Potential profits would have dropped a lot more due to the OPTI:Optibiotix fall, but JLP:Jubilee Metals went into £174 potential profit to offset most of the loss. That also helped the portfolio value creep up by £169.

Flat

Still too far below the trend line

The SIPP looks like this after week 436 overall and week 20 of year 9.

			Weekly Change
Cash	£429.07		+£266.53
Portfolio cost	£107,351.61		+£0
Portfolio sell value (bid price - commission)	£55,459.62	(-48.3%)	-£145.92
Potential profits	£2,808.40		+£254.76
Yr 9 Dividends	£267.71		+£32.14
Yr 9 Interest	£2.59		+£1.05
Yr 9 Profit from sales	£3,506.75		+£0
Yr 9 proj avg monthly profit	£798.78	(13.3%)	-£38.27
Total Dividends	£14,902.59		+£32.14
Total Interest	£8.52		+£1.05
Total Profit from sales	£14,342.65		+£0
Average monthly cash profit	£278.35	(4.6%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

Cash went up thanks to my £250 monthly savings, plus a £32 dividend from APAX:Apax Global Alpha, minus monthly fees and plus £1 interest.

Potential profits went up £254 mainly thanks to CEY:Centamin and CAML:Central Asia Metals, but I have far fewer JLP:Jubilee Metals shares in the SIPP so the rise wasn't enough to prevent a £145 drop in value.

Same as ISA

Also same as ISA

The trading account looks like this after week 402 overall and week 38 of year 8.

			Weekly Change
Cash	£63.39		+£16.80
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,411.23	(-32.0%)	+£147.24
Potential profits	£56.30		+£56.30
Year 8 Dividends	£25.36		+£16.80
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£40.31	(+23.3%)	+£0.88
Dividends	£85.46		+£16.80
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.57	(-3.2%)	+£0.20
(Sold stocks profit + Dividends - Fees / Months)

One of my best trading account weeks, with a £16 dividend from BARC:Barclays and a huge rise in JLP:Jubilee Metals which coped well with the big drop in SBTX:SkinBioTherapeutics. Portfolio value improved by £147 and my recent JLP holding is making £56 potential profit. I'm planning to sell at 11.5p which will be enough to put my long term performance back to positive.

A very welcome spike

Smashes through the trend line in style!

I'm feeling much more positive after the JLP:Jubilee Metals surge, and the steady progress of CAML:Central Asia Metals, a share which has never surged, but which should be a lot stronger than it is. My holding cost £7,634 but £1,002 of that is in my ISA. That holding is 27% down, but I plan to sell it and get my SIPP holding up to £10,000. I'll need to spend £3,368 to do that, which I can get by selling one of my JLP:Jubilee Metals holdings if the current momentum continues and takes it into profit.

My JLP ISA holding cost £14k so that's already above my £10k target, and I probably shouldn't go above that amount on one company. £5k of that is in my dealing account so I'll need to bed & ISA it round about break-even as I'll be exposed to capital gains tax and the threshold is pitifully low. In fact to avoid potential issues with delayed sale I may have to "borrow" the cash to put in my ISA from my bank account rather than transferring from my dealing account else I could miss out on a chunk of the rise. Then I just bank the proceeds from the sale to replace what I put in. What could possibly go wrong?

Week 451 Review - What would have been a great week ruined by Optibiotix placing.

This would have been a really good week, with most shares doing well, but a 3.5p drop in OPTI:Optibiotix on news of a discounted placing meant a big drop in portfolio value. The drop should have been over £7,000, but thanks to many other shares doing really well, the damage was limited to £5,240. That increased the deficit between cost and value to £108,953 and the deficit between injection amount and value to £44,647 and dropped the total portfolio value to £101,730.

OPTI:Optibiotix was joint worst performer, dropping 15% to the placing price. It wasn't the only 15% fall, with AFC:AFC Energy also dropping heavily and going from 3% profit to 12% loss. This one is going to be very volatile!

Fortunately they were the only poor performers, and there were great gains elsewhere.

All my gold miners did really well. CEY:Centamin went up 6% and is now 4% in profit, PAF:Pan African Resources climbed 9% and are now 30% and 26% up. EDV:Endeavour Mining had the best week, climbing 10%, but they are still down by 20%.

Share of the Week is SBTX:SkinBioTherapeutics which went up an amazing 56%, and nobody knows why. It might be people closing shorts, but there is no reason for the rise in this week's news. I'm not complaining, and took the opportunity to offload some, as I consider this holding too high risk for my liking now.

Here's the ISA and shares portfolio after week 35 of year 9.

			Weekly Change
Cash	£43.96		-£15.68
Portfolio cost	£101,005.32		+£1,161.88
Portfolio sell value (bid price-commission)	£44,608.25	(-55.8%)	-£2,712.19
Potential profits	£946.65		-£731.96
Yr 9 Dividends	£215.92		+£0
Yr 9 Interest	£3.77		+£0
Yr 9 Profit from sales	£262.11		+£146.20
Yr 9 proj avg monthly profit	£52.69	(0.9%)	+£17.08
Total Dividends	£12,127.35		+£0
Total Interest	£5.70		+£0
Total Profit from sales	£17,560.64		+£146.20
Average monthly cash profit	£281.13	(4.7%)	+£0.78
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

Portfolio cost went up by over £1,000 as I cashed in some premium bonds to buy some more OPTI:Optibiotix in my ISA. My plan is to sell the ones in my SIPP if they get into profit, but I want to stay above 200k shares, so need to stock up in my ISA as a buffer, I have enough to sell my cheapest 3 OPTI holdings in my SIPP if they get to around 50p. I bought 4,719 shares at 21.19p costing £1,009.91

I then sold 9,190 of my SBTX:SkinBioTherapeutics shares for 13.025p making £146.21 (13.9%) profit and used the proceeds to buy 5,603 shares in OPTI:Optibiotix at 21.04p costing £1,190.82. I still have loads of SBTX but they worry me, so the opportunity to reduce my risk was much appreciated.

Both potential profits and portfolio value were hammered and we're back to one of my OPTI:Optibiotix holdings being the only share in profit, and that is very much reduced.

Long slow decline for almost 6 months.

I think we're now lower than the low of a few weeks ago.

The SIPP looks like this after week 435 overall and week 19 of year 9.

			Weekly Change
Cash	£162.54		+£16.35
Portfolio cost	£107,351.61		+£0
Portfolio sell value (bid price - commission)	£55,605.54	(-48.2%)	-£2,618.32
Potential profits	£2,553.64		+£661.81
Yr 9 Dividends	£235.57		+£16.35
Yr 9 Interest	£1.54		+£0
Yr 9 Profit from sales	£3,506.75		+£0
Yr 9 proj avg monthly profit	£837.05	(14.0%)	-£42.57
Total Dividends	£14,870.45		+£16.35
Total Interest	£7.47		+£0
Total Profit from sales	£14,342.65		+£0
Average monthly cash profit	£278.82	(4.7%)	-£0.48
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

Not much happened here, apart from the same big drop in value, but potential profit went up by £661 mainly thanks to my gold mines, CAML:Central Asia Metals and III:3i Group. I also got a £16 dividend from EDV:Endeavour Mining.

A lot flatter looking than the ISA.

Less flat looking. I guess the injections disguise the fall in the other chart.

The trading account looks like this after week 401 overall and week 37 of year 8.

			Weekly Change
Cash	£46.59		+£0
Portfolio cost	£2,073.87		+£0
Portfolio sell value (bid price - commission)	£1,263.99	(-39.1%)	+£90.14
Potential profits	£0		+£0
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£0
Yr 8 proj avg monthly profit	£39.43	(+22.8%)	-£1.10
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£0
Average monthly cash profit	-£5.77	(-3.3%)	+£0.01
(Sold stocks profit + Dividends - Fees / Months)

JLP:Jubilee Metals stayed flat, so the £90 improvement is all thanks to SBTX:SkinBioTherapeutics, which is only 15% down now, so another week like this means I could sell.

Nice little tick up.

Big bounce back to the trend line, Just need to get above it.

There are a few seeds of hope at the moment, and it was good to swap some of my SBTX:SkinBioTherapeutics shares into OPTI:Optibiotix. I think exposure to them via my OPTI holding is a lot safer than owning the shares given the recent death spiral funding which removed all trust I have for the SBTX CEO.

Week 450 Review - A bad week despite FTSE doing well.

A bad week, with most of my holdings down despite the FTSE 100 seeming to do very well. The deficit between cost and value widened by £3,489 to £103,712, and the deficit between injection amount and value widened to £39,569. Total portfolio value dropped to £105,808.

Worst performer again was FXPO:Ferrexpo which is really struggling and dropped another 14% to go 92% down. They should recover once the legal issues die down, which they should do as it appears Ukraine courts are trying to use FXPO to get money owed by their previous director. In theory the worst that should happen is he is forced to sell a large number of shares. There should be no liability on FXPO to pay his personal debts.

OPTI:Optibiotix dropped 1.5p which accounted for a lot of the losses this week. That's a 6% drop and probably due to no microbiome modulator news coming out despite it being expected.

PAF:Pan African Resources has had a great few weeks, but fell 6% this week probably due to some profit taking. Gold is still holding up so these should too. They are still 19% in profit and a rare example of a well timed purchase.

Quite a few shares did well this week, with PSN:Persimmon and WHR:Warehouse REIT both climbing 5% presumably on hopes interest rates will soon drop.

AFC:AFC Energy had another good week and have gone into profit after climbing 6%.

AJB:AJ Bell did a false drop of 8% last week when the bid price was mysteriously marked down. That was sorted out this week, although the 6% gain means we are still 2% down on the week before and 1% down altogether.

CAML:Central Asia Metals had an absolutely brilliant week, being tipped in many places, mainly for their huge dividend yield. They climbed 7% and some of my holdings are now in profit.

Share of the Week was III:3i Group which gave excellent results and went up another 8% to go 69% up since I bought them. At last I have a magic formula share that I can try and hold forever and reap a huge dividend yield.

Here's the ISA and shares portfolio after week 34 of year 9.

			Weekly Change
Cash	£59.64		-£6.68
Portfolio cost	£99,843.44		+£611.52
Portfolio sell value (bid price-commission)	£46,158.56	(-53.8%)	-£1,912.35
Potential profits	£1,678.61		-£258.99
Yr 9 Dividends	£215.92		+£0
Yr 9 Interest	£3.77		+£0.06
Yr 9 Profit from sales	£115.91		+£104.77
Yr 9 proj avg monthly profit	£35.61	(0.6%)	+£12.69
Total Dividends	£12,127.35		+£0
Total Interest	£5.70		+£0.06
Total Profit from sales	£17,414.44		+£104.77
Average monthly cash profit	£280.35	(4.7%)	+£0.39
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I did what I considered last week and sold my profitable CAML:Central Asia Metals holding of 1,175 shares at 180.8p making a profit of £104.77 (5.1%). I immediately re-invested the proceeds in JLP:Jubilee Metals, buying 36,206 shares at 5.8p at a cost of £2,109.90. That fits my policy of having growth shares in the ISA rather than dividend shares.

I also added £500 cash and bought 351 shares in CWR:Ceres Power at 142.123p costing £511.29. That more than doubled my holding and reduced my weighted average price to 213.7957p. I have always liked this company and can't believe they have fallen so far. I'll keep adding at these prices if I can get any cash.

Potential profits went down due to OPTI:Optibiotix and selling CAML:Central Asia Metals, although AFC:AFC Energy went £38 into profit, so I still have two profitable holdings in the ISA.

The sale didn't make much difference to long-term performance.

Hoping we stay above the low from a few weeks ago.

Not looking great.

The SIPP looks like this after week 434 overall and week 18 of year 9.

			Weekly Change
Cash	£146.19		+£24.83
Portfolio cost	£107,351.61		+£216.10
Portfolio sell value (bid price - commission)	£58,223.86	(-45.8%)	-£1,476.46
Potential profits	£1,891.83		+£326.89
Yr 9 Dividends	£219.22		+£45.34
Yr 9 Interest	£1.54		+£0.30
Yr 9 Profit from sales	£3,506.75		+£132.78
Yr 9 proj avg monthly profit	£879.62	(14.7%)	-£6.26
Total Dividends	£14,854.10		+£45.34
Total Interest	£7.47		+£0.30
Total Profit from sales	£14,342.65		+£132.78
Average monthly cash profit	£279.30	(4.7%)	+£1.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	39%		+0%

Very busy! I sold my profitable 39,766 JLP:Jubilee Metals shares at 5.73p making £132.78 (6.1%) profit and in a reverse of the ISA transaction I bought 1,292 shares in CAML:Central Asia Metals at 180.96p costing £2,349.95, taking my SIPP holding to 3,760 shares at an average price of 175.1272p costing £6,632.58. They are currently up by 8% making £522 potential profit.

There was a nice dividend of £45 from IPX:Impax Asset Management, in fact it's such a good dividend I may have to get some more!

Potential profits went up thanks to CAML:Central Asia Metals and III:3i Group, but the gain was reduced by PAF:Pan African Resources dropping 6%.

Not as bad as the ISA

The 8-month trend doesn't look very good.

The trading account looks like this after week 400 overall and week 36 of year 8.

			Weekly Change
Cash	£46.59		+£46.52
Portfolio cost	£2,073.87		-£2.36
Portfolio sell value (bid price - commission)	£1,173.85	(-43.4%)	-£103.32
Potential profits	£0		-£37.51
Year 8 Dividends	£8.56		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£328.15		+£44.16
Yr 8 proj avg monthly profit	£40.53	(+23.5%)	+£4.31
Dividends	£68.66		+£0
Interest	£0.03		+£0
Profit from sales	-£602.54		+£44.16
Average monthly cash profit	-£5.78	(-3.3%)	+£0.50
(Sold stocks profit + Dividends - Fees / Months)

I sold my 317 BARC:Barclays shares at 179.9371p making £44.16 (9.7%) profit. That will be above 10% when the 2 dividends are included. I bought 8,532 shares in JLP:Jubilee Metals at 5.86p costing £511.93 which left £46 in cash. Three of my trading holdings are now in JLP:Jubilee Metals so I'm hoping that doesn't completely curse the company!

Not great as despite the green line including cash, JLP:Jubilee Metals dropped 4% this week.

Profit taking always has a dramatic downer on this chart.

I enjoyed doing the switcheroo on CAML:Central Asia Metals and JLP:Jubilee Metals in my SIPP and ISA. It didn't cost me anything, I registered a few small profits, and I started my gradual differentiation of the two accounts so in future they won't just track each other as they currently have nearly all the same shares.

If I do follow this strategy then I will need to buy some more OPTI:Optibiotix in the ISA to replace the ones I sell in the SIPP, as I don't want to reduce my holding.

Meanwhile I still wait patiently for news from my biggest holdings in the hope I can improve my dreadful performance.